羊膜市场规模、份额和成长分析（按产品、应用、最终用途和地区）- 2025-2032 年产业预测

2023 年羊膜市场规模价值为 45 亿美元，预计将从 2024 年的 51.8 亿美元成长到 2032 年的 159.5 亿美元，预测期间（2025-2032 年）的复合年增长率为 15.1%。

羊膜（AM）是胚胎周围的重要结构，由于眼科和整形外科疾病的发生率不断增加，羊膜在医学领域越来越受到青睐。由于 AM 在外科手术中的优势，越来越多的医生选择 AM 来缩短患者的康復时间。这种不断增长的需求为製造商提供了充足的机会来开发创新的 AM 产品，以优化手术效率。此外，整容手术的兴起可能会进一步刺激市场成长。冷冻保存、生物技术和组织工程领域的最新进展促成了生物相容性支架的诞生以及源自羊水的改良配方。这些技术创新正在增强组织修復、再生和再生调节，从而增强预测期内羊膜市场的潜力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

羊膜市场规模（依产品和复合年增长率） (2025-2032)

• 市场概况
• 冷冻的羊膜
• 脱水羊膜

羊膜市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 手术伤口
• 眼科
• 其他的

羊膜市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 门诊手术中心
• 专科门诊
• 研究和学术机构

羊膜市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• MiMedx Group, Inc.（USA）
• Integra LifeSciences Holdings Corporation.（USA）
• Organogenesis Holdings Inc.（USA）
• Smith & Nephew plc.（UK）
• BioTissue Holdings Inc.（USA）
• Amnio Technology, LLC.（USA）
• Applied Biologics LLC.（USA）
• Celularity Inc.（USA）
• Corza Health, Inc.（USA）
• Skye Biologics, Inc.（USA）
• Human Regenerative Technologies, LLC.（USA）
• Katena Products Inc.（USA）
• TissueTech Inc.（BioTissue）（USA）
• Amniox Medical Inc.（USA）
• Laboratoire CCD.（France）
• VIVEX Biologics Inc.（USA）
• Merakris Therapeutics.（USA）
• Thea Pharma.（France）
• Allosure, Inc.（USA）
• Xtant Medical Holdings Inc.（USA）

结论和建议

Amniotic Membrane Market size was valued at USD 4.5 billion in 2023 and is poised to grow from USD 5.18 billion in 2024 to USD 15.95 billion by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).

The amniotic membrane (AM), a vital structure surrounding the embryo, is gaining traction in the medical field due to the rising prevalence of ophthalmic and orthopedic conditions. Physicians are increasingly opting for AM due to its benefits in surgical procedures, which enhances recovery times for patients. This growing demand presents ample opportunities for manufacturers to develop innovative AM products that optimize surgical efficiency. Additionally, the rise in aesthetic surgical procedures is likely to further stimulate market growth. Recent advancements in cryopreservation, bioengineering, and tissue engineering have led to the creation of biocompatible scaffolds and improved formulations derived from amniotic fluid. These innovations enhance tissue repair, regeneration, and regenerative modulation, reinforcing the amniotic membrane market's potential during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Amniotic Membrane market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Amniotic Membrane Market Segments Analysis

Global Amniotic Membrane Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane. Based on Application, the market is segmented into Surgical Wounds, Ophthalmology and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Amniotic Membrane Market

The rising incidence of severe injuries among workers engaged in field activities is driving the demand for prompt and efficient healing solutions. In particular, road accidents are a leading cause of traumatic injuries in children and young adults. With road safety measures being compromised and traffic congestion intensifying globally, accident rates are surging. This increase in both the number of accidents and resultant trauma directly contributes to the growth of the amniotic membrane market, as it highlights the urgent need for advanced therapeutic options to facilitate faster recovery and healing processes for affected individuals.

Restraints in the Amniotic Membrane Market

The amniotic membrane market faces significant restraints primarily due to the high costs associated with amniotic products and their related services. These products require specialized biological processing and manufacturing techniques to preserve their natural properties and ensure safety. The necessity for rigorous quality control, extensive testing, and adherence to regulatory standards complicates these processes, further escalating production expenses. As a result, patients, suppliers, and healthcare systems may find it challenging to access or afford these advanced treatments, potentially hindering market growth and limiting overall patient care options within the sector.

Market Trends of the Amniotic Membrane Market

The amniotic membrane market is witnessing significant growth driven by improving healthcare policies in emerging economies such as China, India, South Korea, Brazil, and Mexico. These nations present lucrative opportunities due to reduced regulatory hurdles, enhanced healthcare infrastructure, and a rapidly increasing patient population. Rising healthcare expenditures further bolster market expansion, while more flexible governance models promote pro-business environments compared to developed markets. Consequently, established players are increasingly targeting these regions to capitalize on their competitive advantages, fueling a robust demand for amniotic membrane products in regenerative medicine and surgical applications, thus shaping a dynamic landscape in the global market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Amniotic Membrane Market Size by Product & CAGR (2025-2032)

• Market Overview
• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

Global Amniotic Membrane Market Size by Application & CAGR (2025-2032)

• Market Overview
• Surgical Wounds
• Ophthalmology
• Others

Global Amniotic Membrane Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes and Academic Institutes

Global Amniotic Membrane Market Size & CAGR (2025-2032)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• MiMedx Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTissue Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biologics LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celularity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skye Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Regenerative Technologies, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Katena Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech Inc. (BioTissue) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amniox Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire CCD. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVEX Biologics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merakris Therapeutics. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allosure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations